
MedSynapse, the largest and fastest-growing global platform for medical professionals, is pleased to announce the appointment of Parag Belsare to the role of AVP Sales.
In this pivotal role, Parag will be spearheading MedSynapse’s strategic expansion into the healthtech market by driving ground-up revenue growth and building high-value partnerships within the pharmaceutical sector. Operating as a hands-on growth driver who thrives in fast-paced startup environments, he specializes in building businesses from the ground up, navigating the complete sales cycle, and developing impactful digital strategies for the pharma industry.
Charles Meyer, CEO at MedSynapse, commented on the appointment: “Parag is a results-driven sales leader with a profound passion for healthcare innovation. His ability to operate as an independent, full-cycle hunter and his deep industry intelligence make him the ideal leader to establish and aggressively scale our footprint in the healthtech ecosystem.“
Parag’s focus at MedSynapse will span five core strategic areas:
- Scaling Market Presence: Leading the charge to establish and aggressively scale MedSynapse’s footprint in the healthtech ecosystem.
- Digital Pharma Solutions: Partnering directly with pharma marketing and brand managers to understand their digital strategies and present tailored HCP engagement solutions.
- Hands-on Dealmaking: Operating as an independent, full-cycle “hunter” responsible for generating fresh leads, owning the sales pipeline, and closing projects in a fast-paced environment.
- Strategic Networking: Leveraging deep industry intelligence and an extensive network to foster long-term relationships within the commercial divisions of top pharmaceutical companies.
- Revenue Ownership: Driving ambitious sales initiatives to consistently meet and exceed target metrics.
“I am passionate about healthcare innovation and transforming how pharmaceutical brands connect with medical professionals,” said Parag Belsare. “As AVP of Sales, my core focus is partnering directly with pharma brand managers and marketers to deliver cutting-edge digital HCP engagement and medical communication solutions.“
About MedSynapse:
MedSynapse is an AI-enabled HCP platform dedicated to transforming how Pharma and MedTech firms engage with over 1.5 healthcare professionals worldwide. Through predictive modelling and data intelligence, MedSynapse provides the critical infrastructure necessary for commercial success and clinical impact across the globe.










